GSE205556 bexarotene 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE205556_bexarotene_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE205556_bexarotene_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE205556_bexarotene_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE205556_bexarotene_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

zinc finger protein 204, pseudogene

Gene

clustered mitochondria homolog pseudogene 3

Gene

TMEM161B divergent transcript

Gene

HLA-F antisense RNA 1

Gene

cervical cancer associated DHX9 suppressive transcript

Gene

GOT1 divergent transcript

Gene

uncharacterized LOC101929532

Gene

transmembrane protein 217B

Gene

FLNB antisense RNA 1

Gene

IL21 antisense RNA 1

  • Gene

    zinc finger protein 204, pseudogene


  • Gene

    clustered mitochondria homolog pseudogene 3


  • Gene

    TMEM161B divergent transcript


  • Gene

    HLA-F antisense RNA 1


  • Gene

    cervical cancer associated DHX9 suppressive transcript


  • Gene

    GOT1 divergent transcript


  • Gene

    uncharacterized LOC101929532


  • Gene

    transmembrane protein 217B


  • Gene

    FLNB antisense RNA 1


  • Gene

    IL21 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.